IDEXX Laboratories
IDXX
$468.94
Share price
2.38%
Change (1 day)
19.74%
Change (1 year)
Categories
Revenue for IDEXX Laboratories (IDXX)
Revenue in 2023 (TTM): $3.43 B
According to IDEXX Laboratories's latest financial reports the company's current revenue (TTM) is $3.43 B. In 2022 the company made a revenue of $3.36 B an increase over the years 2021 revenue that were of $3.21 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for IDEXX Laboratories from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $3.43 B | 1.89% |
| 2022 | $3.36 B | 4.73% |
| 2021 | $3.21 B | 18.79% |
| 2020 | $2.70 B | 12.45% |
| 2019 | $2.40 B | 8.75% |
| 2018 | $2.21 B | 12.4% |
| 2017 | $1.96 B | 10.91% |
| 2016 | $1.77 B | 10.83% |
| 2015 | $1.60 B | 7.81% |
| 2014 | $1.48 B | 7.9% |
| 2013 | $1.37 B | 6.47% |
| 2012 | $1.29 B | 6.13% |
| 2011 | $1.21 B | 10.45% |
| 2010 | $1.10 B | 6.96% |
| 2009 | $1.03 B | 0.74% |
| 2008 | $1.02 B | 11% |
| 2007 | $0.92 B | 24.82% |
| 2006 | $0.73 B | 15.83% |
| 2005 | $0.63 B | 16.19% |
| 2004 | $0.54 B | 15.38% |
| 2003 | $0.47 B | 15.34% |
| 2002 | $0.41 B | 6.89% |
| 2001 | $0.38 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $41.50 B | 1,109.72% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $43.80 B | 1,176.81% | 🇺🇸 USA |
 Henry Schein
HSIC | $12.52 B | 265.14% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.33 B | -90.29% | 🇺🇸 USA |
 Neogen NEOG | $0.72 B | -78.99% | 🇺🇸 USA |
 Heska Corporation
HSKA | $0.25 B | -92.57% | 🇺🇸 USA |
 Petco WOOF | $6.11 B | 78.26% | 🇺🇸 USA |